$4.85
-0.0800 (-1.62%)
At Close: Aug 04, 2026
INJ Price Prediction: $6.20 Target by February 2026 as Technical Indicators Signal Recovery
07:51am, Monday, 05'th Jan 2026
Injective (INJ) shows bullish momentum with MACD histogram turning positive and RSI in neutral territory, targeting $6.20 within 4-6 weeks as analysts eye $5.80-$6.50 range.
INJ Price Prediction: Targeting $5.80-$6.50 Recovery Within 30 Days
08:34am, Friday, 02'nd Jan 2026
Injective showing bullish MACD signals and neutral RSI positioning for potential recovery to $5.80-$6.50 range, with critical resistance at $5.42 determining next move.
INJ Price Prediction: Targeting $5.80-$6.50 Recovery by End of January 2026
07:46am, Thursday, 01'st Jan 2026
INJ price prediction points to potential 25-50% upside to $5.80-$6.50 range as technical indicators show early bullish momentum despite current weakness at $4.32.
INJ Price Prediction: Targeting $6.50-$7.20 Recovery Despite Current Weakness
03:29am, Wednesday, 31'st Dec 2025
Injective faces critical support at $4.35 with bullish MACD signals suggesting potential 45-60% recovery to $6.50-$7.20 range within 4-6 weeks if key resistance breaks.
Injective launches research page for seamless access to technical papers and insights
12:09pm, Tuesday, 30'th Dec 2025
Injective's research page enhances transparency and accessibility, potentially fostering innovation and informed regulatory discussions in blockchain. Injective launches research page for seamless acc
INJ Price Prediction: Target $5.20-5.80 by January 2026 Based on Emerging Bullish Momentum
09:47am, Tuesday, 30'th Dec 2025
INJ price prediction shows potential recovery to $5.20-5.80 range within 4-6 weeks as MACD histogram turns positive and RSI rebounds from oversold conditions.
INJ Price Prediction: Targeting $4.84 Recovery Before Potential $3.36 Decline in January 2026
05:17am, Saturday, 27'th Dec 2025
INJ price prediction shows mixed signals with short-term bounce to $4.84 possible, but medium-term Injective forecast warns of $3.36 target amid bearish momentum.
INJ Price Prediction: Injective Eyes $4.84 Recovery Before Targeting $7.50-$8.00 by January 2026
05:58am, Thursday, 25'th Dec 2025
INJ price prediction shows potential recovery to $4.84 within days, with medium-term Injective forecast targeting $7.50-$8.00 range as technical indicators signal bullish momentum.
INJ Price Prediction: Targeting $4.84 Recovery by Year-End Despite Bearish Momentum
02:30am, Wednesday, 24'th Dec 2025
INJ price prediction points to $4.84 target by December 26 as technical analysis reveals potential bounce from $4.72 support, though bearish momentum persists.
INJ Price Prediction: Targeting $4.84-$4.93 Recovery by January 2025
06:18am, Tuesday, 23'rd Dec 2025
INJ price prediction suggests recovery to $4.84-$4.93 range within 30 days as technical indicators show oversold conditions near Bollinger Band support at $4.26.
INJ Price Prediction: Target $4.84 by Week-End Amid Mixed Signals
04:42am, Monday, 22'nd Dec 2025
INJ price prediction points to $4.84 recovery by December 26, despite current bearish momentum. Critical $4.72 support level holds the key for Injective's near-term direction.
Canary Capital Polishes Injective Staking Proposal
01:44pm, Thursday, 18'th Dec 2025
TLDR: The technical amendment defines BitGo as custodian and U.S. Bancorp for cash management. The fund plans to delegate all its assets to staking providers to generate yields. INJ price faces a tech
Canary Capital Files for Staked Injective ETF, Will INJ Price Recover From 30% Monthly Drop?
10:07am, Thursday, 18'th Dec 2025
Canary Capital has submitted an S-1 filing to the U.S. SEC for a staked Injective ETF that would list on Cboe.
Injective bulls eye ETF milestone as Canary refiles staked INJ S-1 with SEC
08:57am, Thursday, 18'th Dec 2025
Canary refiles S-1 for a staked Injective ETF, detailing custodians, staking plan, and Cboe BZX listing as INJ price and derivatives markets show mixed signals. Canary Capital has filed an amended S-1
Canary Capital files revised S-1 for its proposed staked INJ ETF
08:14am, Thursday, 18'th Dec 2025
Canary Capital has filed a revised S-1 registration statement with the US Securities and Exchange Commission (SEC) for its proposed staked INJ exchange-traded fund (ETF).
Sign In
Buy INJUSD